コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 CRISPR-Cas9 is to be used in the practice of cardiovascular medicine.
2 ial for more refined, targeted approaches to cardiovascular medicine.
3 o discover unknown drug-drug interactions in cardiovascular medicine.
4 the heart has the potential to revolutionize cardiovascular medicine.
5 D risk is a key new question in the field of cardiovascular medicine.
6 s already known about specific treatments in cardiovascular medicine.
7 properties have remained at the forefront of cardiovascular medicine.
8 en significant areas of research interest in cardiovascular medicine.
9 frailty has become a high-priority theme in cardiovascular medicine.
10 ting and important questions in the field of cardiovascular medicine.
11 that illuminates new therapeutic promise in cardiovascular medicine.
12 e on how to incorporate genetic testing into cardiovascular medicine.
13 health monitoring and remote diagnostics in cardiovascular medicine.
14 ardiac tissue has the potential to transform cardiovascular medicine.
15 llowing injury represents a major barrier in cardiovascular medicine.
16 lar function and their clinical relevance to cardiovascular medicine.
17 ty of radiation use in the practice of adult cardiovascular medicine.
18 nome and exome sequencing in the practice of cardiovascular medicine.
19 ng toward a therapeutic goal of regenerative cardiovascular medicine.
20 ng faces to fulfill its promises in clinical cardiovascular medicine.
21 th of advanced infection-targeted imaging in cardiovascular medicine.
22 f high-powered, comprehensive, personalized, cardiovascular medicine.
23 and novel approaches for human regenerative cardiovascular medicine.
24 ndation for novel approaches in regenerative cardiovascular medicine.
25 e critical role of body size measurements in cardiovascular medicine.
26 sceptibility testing, and prognostication in cardiovascular medicine.
27 eat promise for transforming the practice of cardiovascular medicine.
28 ellular matrix components, and drugs used in cardiovascular medicine.
29 o the beneficial effects of beta-blockers in cardiovascular medicine.
30 ly become the next horizon for strategies in cardiovascular medicine.
31 ial therapeutic opportunities for ghrelin in cardiovascular medicine.
32 rombin and its receptors to the forefront of cardiovascular medicine.
33 en focused on quality than in other areas of cardiovascular medicine.
34 technique and suggest future applications in cardiovascular medicine.
35 nty and change attitudes about treatments in cardiovascular medicine.
36 d new avenues of opportunity in the field of cardiovascular medicine.
37 n important limitations and implications for cardiovascular medicine.
38 herapeutic techniques under investigation in cardiovascular medicine.
39 c angiogenesis) is a an exciting frontier of cardiovascular medicine.
40 ty of these approaches within the context of cardiovascular medicine.
41 vidence on herbal medications mostly used in cardiovascular medicine.
42 ury, present major therapeutic challenges in cardiovascular medicine.
43 ially affect diagnostics and therapeutics in cardiovascular medicine.
44 ve been immensely successful in creating new cardiovascular medicines.
45 histology, embryology, and adipogenesis) and cardiovascular medicine; 3) outlines the anatomic, funct
46 ation between fundamental cancer biology and cardiovascular medicine, a set of metabolic observations
47 ertise in critical care, pulmonary medicine, cardiovascular medicine and surgery, pediatrics, nursing
48 emerging protein engineering technologies to cardiovascular medicine and the barriers that must be ov
49 rapeutic insights relevant to hematology and cardiovascular medicine, and further advances can be ant
51 ity have the potential to hinder progress in cardiovascular medicine as preclinical research often pr
53 nancial conflicts of interest, ubiquitous in cardiovascular medicine because of significant investiga
55 haemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of th
56 ise of becoming a key diagnostic modality in cardiovascular medicine by allowing visualization of spe
57 tly been noteworthy advances in the field of cardiovascular medicine, cardiovascular case fatalities
58 the context of the Century Health Study for Cardiovascular Medicine (Century Trial), a 1,300-patient
59 the benefits of clinical genetic testing in cardiovascular medicine, clinicians must implement sever
62 vide insight into the future of personalized cardiovascular medicine from a regulatory perspective.
65 Importantly, recent advances in the field of cardiovascular medicine have not led to significant decl
66 ingle most important observation in clinical cardiovascular medicine in 1995 was the reporting of a h
67 njection (DHI) is one of the most prescribed cardiovascular medicines in China, its therapeutic indic
68 mportant associations of pharmacogenomics in cardiovascular medicine include clopidogrel and risk for
69 nterrogated a number of relevant advances in cardiovascular medicine, including widespread fee-for-se
73 ere is growing evidence that the practice of cardiovascular medicine might soon have a new toolbox to
74 were selected by NHLBI staff and represented cardiovascular medicine, obstetrics, immunology, and pat
76 ogy completed this white paper to inform the cardiovascular medicine profession regarding the plight
77 sessed 303 consecutive superiority trials of cardiovascular medicine published between January 1, 200
78 h a model would serve as a basic approach to cardiovascular medicine that is necessary, but not suffi
79 the right ventricle (RV) in many aspects of cardiovascular medicine, there has been surprisingly lit
80 reviews, we summarize advances in access to cardiovascular medicines using the 5 health system dimen
82 e most widely discussed and debated topic in cardiovascular medicine, with its incidence increasing d
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。